Bio-Sourcing and Zerion Pharma have announced that their collaboration to develop an oral form of the monoclonal antibody trastuzumab for breast cancer has received 1.3m euros in funding from EUREKA Eurostars. The collaboration combines Bio-Sourcing’s BioMilk platform, designed to transport...
Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed to invest in pre-clinical and early clinical-stage biotechnology companies whose work has the potential to address high unmet medical need. Arkin Bio Ventures III builds on two previous funds, Arkin Bio...
Alto Neuroscience, a clinical-stage biopharmaceutical company specialising in precision treatments for neuropsychiatric conditions, has announced the issuance of a US patent for methods of treating depression with Alto’s ALTO-207 (pramipexole and ondansetron). The patent protects the use of...
Longtime Ubisoft writer Christopher Grilli, whose credits include Origins, Odyssey, Valhalla, Far Cry 5, and New Dawn, has returned to the company after two years as lead scriptwriter on Assassin’s Creed Hexe, believed to be the next instalment in the series.
Continue reading →
The kefir maker is capitalizing on demand for premium butters, while Horizon Organic splashes into the fast-growing creamer category.
Continue reading →
The canned fruit and vegetable company sold a portion of its assets to the unrelated produce giant Fresh Del Monte for $285 million.
Continue reading →